Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05933161 · ClinicalTrials.gov registry record
A Study of Glycemic Control in Left Ventricular Assist
A clinical trial of Type 2 Diabetes Mellitus and Hypoglycemia, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05933161 is a study of Type 2 Diabetes Mellitus and Hypoglycemia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05933161, a study of Type 2 Diabetes Mellitus and Hypoglycemia, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is being conducted to understand if the hemoglobin A1c, a measurement of control of blood sugars over a 3-month time, is valid in patients with Left Ventricular Assist Devices (LVADs) in place. To understand whether it is an adequate measurement, the investigators will compare the A1c to results from a continuous glucose monitor (CGM) measurement of blood sugars. By monitoring blood sugars continuously, the investigators will also assess whether they can get better control of blood sugars with a CGM, including avoiding low blood sugars.
Conditions Studied
Interventions
- DEVICE Freestyle Libre 3 Continuous Glucose Monitor (CGM)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-11-10 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05933161
The ClinicalTrials.gov registry entry for NCT05933161 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Freestyle Libre 3 Continuous Glucose Monitor (CGM) is the first listed.
NCT05933161 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05933161 about?
NCT05933161 is a clinical study titled "A Study of Glycemic Control in Left Ventricular Assist". The study is being conducted to understand if the hemoglobin A1c, a measurement of control of blood sugars over a 3-month time, is valid in patients with Left Ventricular Assist Devices (LVADs) in place. To understand whether it is an adequate measurement, the investigators will compare the A1c to r...
What is the current status of trial NCT05933161?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2023-11-10. Estimated completion is 2026-07.
What conditions does trial NCT05933161 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Hypoglycemia, Hyperglycemia.
What interventions are being tested in trial NCT05933161?
The interventions under investigation include: Freestyle Libre 3 Continuous Glucose Monitor (CGM) (DEVICE).
Who is sponsoring clinical trial NCT05933161?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05933161 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
RECRUITING
-
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
-
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
RECRUITING
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
RECRUITING
-
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.